Incorporating neoadjuvant chemotherapy into locally advanced colon cancer treatment pathways: Real-life experience of implementing FOxTROT.
Christopher J M WilliamsRebecca FishLucy AkermanNicholas P WestDamian TolanAaron J QuynJenny F SeligmannPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
Use of NAC for locally advanced colon cancer has been shown to improve surgical outcomes and longer term cancer outcomes. Provision of NAC requires some modifications to current treatment pathways but can be delivered with team working and without the requirement for additional resources.